Sanford Burnham Prebys Medical Discovery Institute
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sanford Burnham Prebys Medical Discovery Institute
$47.5m partnership between the foundation and Broad researchers will mine genetic data for insights into disease mechanisms. MD Anderson, Nuvectis each unveil multiple new tie-ups.
The intellectual property, also held by Eureka, may offer a new pathway for treating relapsed MM patients. Sorrento inks cancer partnerships with Karolinska Institutet and Mayo Clinic.
TNX-1600 joins two other candidates, including Phase III TNX-102 SL, in Tonix’s PTSD portfolio. CureVac and Yale partner on mRNA therapies for pulmonary disease.
Bayer will collaborate with start-up Hope Medicine to develop antibody therapies targeting the PRL receptor. WARF and Sanford Burnham Prebys partner on translational research.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Sanford-Burnham Medical Research InstituteSanford Burnham Prebys Medical Discovery Institute
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.